The production of anti-inflammmatory cytockines in whole blood by physico-chemical induction

被引:134
作者
Meijer, H
Reinecke, J
Becker, C
Tholen, G
Wehling, P
机构
[1] Praxis & Klin Orthopad & Neurochirurg, D-40212 Dusseldorf, Germany
[2] ORTHOGEN Lab Serv, D-40212 Dusseldorf, Germany
[3] ORTHOGEN Therapeut GmbH, D-40212 Dusseldorf, Germany
[4] St Josef Hosp, Orthopad Univ Klin, D-44791 Bochum, Germany
关键词
cytokine; degenerative spine disease; IL-1Ra; osteoarthritis; orthokine; INTERLEUKIN-1 RECEPTOR ANTAGONIST; GENE-THERAPY; IN-VIVO; HUMAN-MONOCYTES; EXPERIMENTAL OSTEOARTHRITIS; KNEE-JOINTS; ARTHRITIS; IL-1; SUPPRESSION; EXPRESSION;
D O I
10.1007/s00011-003-1197-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective and design: Cytokines such as interleukin-1 (IL-1) play an important role in degenerative musculo-skeletal diseases, including osteoarthritis, and a multitude of inflammatory disorders. Agents that inhibit the action of such cytokines have a high therapeutic potential in such diseases. Here we describe a new method for enhancing the production of the interleukin-1 receptor antagonist (IL-1Ra) and other anti-inflammatory cytokines in whole blood. Material and methods: Human venous blood was incubated in the presence of CrSO4-treated glass beads. Serum was recovered and the concentrations of IL-1Ra and other relevant cytokines were measured by ELISA. Results: The interaction of the glass bead surface with cells in whole blood increased production of IL-1Ra and antiinflammatory cytokines. Removal of the beads and centrifugation generated a serum preparation enriched in antiinflammatory cytokines. This preparation is of therapeutic value in treating various inflammatory and degenerative disorders. Conclusions: The increased de novo production of antiinflammatory cytokines by a direct physico-chemical induction of whole blood in the Orthokin system is feasible and offers an alternative, novel approach to treating mild to moderate OA and other orthopaedic conditions such as degenerative spine diseases.
引用
收藏
页码:404 / 407
页数:4
相关论文
共 19 条
[1]  
AREND WP, 1991, J IMMUNOL, V147, P1530
[2]  
AREND WP, 1985, J IMMUNOL, V134, P3868
[3]   IGG INDUCTION OF IL-1 RECEPTOR ANTAGONIST PRODUCTION BY HUMAN MONOCYTES [J].
AREND, WP ;
LEUNG, DYM .
IMMUNOLOGICAL REVIEWS, 1994, 139 :71-78
[4]   Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis - Suppression of collagenase-1 expression [J].
Caron, JP ;
Fernandes, JC ;
MartellPelletier, J ;
Tardif, G ;
Mineau, F ;
Geng, CS ;
Pelletier, JP .
ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1535-1544
[5]   BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO [J].
DINARELLO, CA ;
THOMPSON, RC .
IMMUNOLOGY TODAY, 1991, 12 (11) :404-410
[6]   INTERLEUKIN-1 [J].
DINARELLO, CA .
REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (01) :51-95
[7]   Clinical trials in the gene therapy of arthritis [J].
Evans, CH ;
Ghivizzani, SC ;
Herndon, JH ;
Wasko, MC ;
Reinecke, J ;
Wehling, P ;
Robbins, PD .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (379) :S300-S307
[8]   In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints -: Prevention of osteoarthritis progression [J].
Fernandes, J ;
Tardif, G ;
Martel-Pelletier, J ;
Lascau-Coman, V ;
Dupuis, M ;
Moldovan, F ;
Sheppard, M ;
Krishnan, BR ;
Pelletier, JP .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :1159-1169
[9]  
FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347
[10]   Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene [J].
Frisbie, DD ;
Ghivizzani, SC ;
Robbins, PD ;
Evans, CH ;
McIlwraith, CW .
GENE THERAPY, 2002, 9 (01) :12-20